Project Details
| Status | Active |
|---|---|
| Effective start/end date | 18/09/2023 → 17/09/2026 |
Collaborative partners
- King's College London (lead)
- Viewpoint Molecular Targeting, Inc.
Funding
- MRC Medical Research Council: £867,781.00
MICA/NIRG - Radiobiology for effective alpha particle and Auger electron molecular radionuclide therapy in neuroendocrine cancer
- Terry, Samantha (Primary Investigator)
Project: Research